Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Peapack-Gladstone Financial
PGC
$823M
| $976K | ﹤0.01% |
35,040
+8,508
| +32% | +$232K |
|
3402
PUT
Bitdeer Technologies
BTDR
$2.38B
| $975K | ﹤0.01% |
87,000
-63,000
| -42% | -$1.02M |
|
3403
Koppers
KOP
$874M
| $973K | ﹤0.01% |
35,939
+6,196
| +21% | +$173K |
|
3404
Liberty Latin America Class A
LILA
$1.67B
| $971K | ﹤0.01% |
193,463
+23,267
| +14% | +$128K |
|
3405
PUT
Lumen
LUMN
$6.61B
| $971K | ﹤0.01% |
125,000
| – | – |
|
3406
Forestar Group
FOR
$1.51B
| $969K | ﹤0.01% |
39,357
+7,361
| +23% | +$188K |
|
|
ADAM
3407
Adamas Trust
ADAM
$907M
| $968K | ﹤0.01% |
132,671
-81,899
| -38% | -$581K |
|
3408
Wendy's
WEN
$1.65B
| $968K | ﹤0.01% |
116,152
-24,878
| -18% | -$215K |
|
3409
Usana Health Sciences
USNA
$252M
| $967K | ﹤0.01% |
49,271
+18,068
| +58% | +$375K |
|
|
NFBK
3410
DELISTED
Northfield Bancorp
NFBK
| $967K | ﹤0.01% |
84,601
+4,970
| +6% | +$55.1K |
|
3411
CALL
Roku
ROKU
$22.9B
| $966K | ﹤0.01% |
8,900
-13,800
| -61% | -$1.4M |
|
3412
Karat Packaging
KRT
$953M
| $965K | ﹤0.01% |
42,766
+1,102
| +3% | +$25.5K |
|
|
AXIA.PRC
3413
DELISTED
AXIA Energia American Depositary Shares Preferred Class C
AXIA.PRC
| $960K | ﹤0.01% |
+111,403
| New | +$962K |
|
3414
CALL
iQIYI
IQ
$1.31B
| $960K | ﹤0.01% |
500,000
| – | – |
|
3415
Luxfer Holdings
LXFR
$457M
| $960K | ﹤0.01% |
70,947
+4,055
| +6% | +$52.8K |
|
3416
PUT
UiPath
PATH
$8.64B
| $959K | ﹤0.01% |
+58,500
| New | +$910K |
|
3417
Daily Journal
DJCO
$828M
| $958K | ﹤0.01% |
1,966
-100
| -5% | -$44.4K |
|
|
SRTA
3418
Strata Critical Medical Inc
SRTA
$528M
| $956K | ﹤0.01% |
198,772
+15,018
| +8% | +$72.6K |
|
3419
NexGen Energy
NXE
$6.96B
| $955K | ﹤0.01% |
103,809
+60,048
| +137% | +$530K |
|
3420
Better Home & Finance Holding
BETR
$21.6M
| $955K | ﹤0.01% |
29,310
+9,554
| +48% | +$516K |
|
3421
Personalis
PSNL
$1.54B
| $955K | ﹤0.01% |
119,951
+5,148
| +4% | +$45K |
|
3422
iHeartMedia
IHRT
$466M
| $953K | ﹤0.01% |
229,205
+19,793
| +9% | +$74K |
|
3423
AMN Healthcare
AMN
$1.33B
| $952K | ﹤0.01% |
60,395
-256,839
| -81% | -$4.58M |
|
3424
iShares MSCI Australia ETF
EWA
$1.45B
| $950K | ﹤0.01% |
36,256
-3,532
| -9% | -$93.5K |
|
|
CWEN.A
3425
DELISTED
Clearway Energy Class A
CWEN.A
| $945K | ﹤0.01% |
30,071
-15,872
| -35% | -$497K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.